Tekla Life Sciences Investors share price logo

Tekla Life Sciences Investors Share Price

NYSE: HQL

Small Cap

$18.09

+0.20

(+1.09%)

as on

Tekla Life Sciences Investors Stock Performance

as on April 18, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $17.87
    $18.10
    downward going graph

    1.22%

    Downside

    0.06%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $11.72
    $17.96
    downward going graph

    35.21%

    Downside

    -0.72%

    Upside

    downward going graph

Tekla Life Sciences Investors share price movements today

Previous Close
$17.89
Open
$17.95
Volume
431.5K
Day's Low - High
$17.87 - $18.10
52 Week Low - High
$11.72 - $17.96

Tekla Life Sciences Investors Historical Returns

1 Month Return
+ 7.64 %
3 Month Return
+ 7.71 %
1 Year Return
+ 51.35 %
3 Year Return
+ 26.25 %
5 Year Return
-10.82 %

Tekla Life Sciences Investors Stock Fundamentals & Key Indicators

Check Tekla Life Sciences Investors market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$541.6M

EPS (TTM)

0

Dividend Yield

0.00%

PE Ratio (TTM)

6.38

Industry PE ratio

4.086455696202532

PEG Ratio

0

Return On Equity TTM

17.59%

Tekla Life Sciences Investors Stock Valuation

Track how Tekla Life Sciences Investors P/E has moved over time to understand its valuation trends.

Tekla Life Sciences Investors in the last 5 years

  • Overview

  • Trends

Lowest (-9.64x)

September 30, 2024

Industry (4.09x)

April 17, 2026

Today (6.38x)

April 17, 2026

Highest (66.59x)

March 31, 2022

LowHigh

Today’s Price to Earnings Ratio: 6.38x

Tekla Life Sciences Investors vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Tekla Life Sciences Investors with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
Tekla Life Sciences Investors image
Tekla Life Sciences Investors
NA$541.6M-10.82%6.384415.74%
Brookfield Corp image
Brookfield Corp
BUY$103.9BNA93.781.68%
KKR & Co LP image
KKR & Co LP
BUY$96.2B91.37%44.389.24%
Blackstone Group Inc image
Blackstone Group Inc
HOLD$159.1B61.62%33.6421.24%
Brookfield Asset Management Inc image
Brookfield Asset Management Inc
BUY$80.0B5.23%31.7151.59%

Stock Returns calculator for Tekla Life Sciences Investors Stock including INR - Dollar returns

The Tekla Life Sciences Investors stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Tekla Life Sciences Investors investment value today

Current value as on today

₹1,65,833

Returns

₹65,833

(+65.83%)

Returns from Tekla Life Sciences Investors Stock

₹53,046 (+53.05%)

Dollar Impact

₹12,788 (+12.79%)

Tekla Life Sciences Investors Stock’s Investor Sentiment and Interest

Search interest for Tekla Life Sciences Investors Stock has decreased by -17% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-17% versus previous 30 day period

Tekla Life Sciences Investors Quarterly Profit & Loss

All numbers in Millions USD

Jun 2022
Sep 2022
Dec 2022
Mar 2023
Sep 2023
Dec 2023
Mar 2024
Sep 2024
Mar 2025
Sep 2025
Total Revenue
0
21
0
1
29
2
2
1
18
11
Gross Profit
0
19
0
1
26
2
2
1
-
9
Operating Income
0
-28
0
0
-11
0
0
-1
-47
132
EBITDA
0
-27
0
33
-11
101
100
-
-47
132
Interest Expense
-
-
-
-
-
-
-
-
-
-
Depreciation
-
-
-
-
-
-
-
-
-
-
Income Before Tax
0
-28
0
33
-11
50
50
35
-47
132
Income Tax Expense
-13
0
17
0
0
25
0
-
-
-
Net Income
0
-28
0
33
-11
50
50
35
-47
132
Net Profit Margin
-1787.46%
-130.50%
1752.05%
1752.11%
-38.73%
2433.42%
2433.42%
1830.03%
-259.55%
1141.76%

Tekla Life Sciences Investors Annual Profit & Loss

All numbers in Millions USD

Sep 2016
Sep 2017
Sep 2018
Sep 2019
Sep 2020
Sep 2021
Sep 2022
Sep 2023
Sep 2024
Sep 2025
Total Revenue
6
69
1
-69
124
65
-103
23
86
86
Gross Profit
1
65
1
-69
124
65
-103
23
86
86
Operating Income
-3
-3
-3
-70
123
64
-104
22
85
85
EBITDA
-20
68
60
-70
123
64
-104
22
87
85
Interest Expense
8
72
32
67
-
-
-
-
-
-
Depreciation
-
-
-
-
-
-
-
-
-
-
Income Before Tax
-11
68
28
-70
123
64
-104
22
85
85
Income Tax Expense
26
0
0
-2
-2
-4
-2
22
-
-
Net Income
-11
68
28
-70
123
64
-104
22
85
85
Net Profit Margin
-189.30%
98.20%
1443.44%
101.64%
99.17%
98.24%
101.31%
95.02%
98.40%
99.08%

Tekla Life Sciences Investors Quarterly Cash Flow

All numbers in Millions USD

Dec 2021
Mar 2022
Jun 2022
Sep 2022
Dec 2022
Mar 2023
Sep 2023
Mar 2025
Sep 2025
Net Income
0
0
0
0
0
33
11
-47
132
Operating Cash Flow
-
-
-
-
-
-
-
-1
-1
Investing Cash Flow
-
-
-
-
-
-
-
4
20
Financing Cash Flow
-
-
-
-
-
-
-
-8
-23
Change in Cash
0
0
0
0
0
0
0
-
0

Tekla Life Sciences Investors Annual Cash Flow

All numbers in Millions USD

Sep 2017
Sep 2018
Sep 2019
Sep 2020
Sep 2021
Sep 2022
Sep 2023
Sep 2024
Sep 2025
Net Income
0
0
0
0
0
0
22
85
85
Operating Cash Flow
-
-
-
-
-
-
-
-
-2
Investing Cash Flow
-
-
-
-
-
-
-
-
25
Financing Cash Flow
-
-
-
-
-
-
-
-
-31
Change in Cash
-
-
1
-
0
0
0
-
0

Insights on Tekla Life Sciences Investors

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, -47.23M → 132.82M (in $), with an average increase of 135.6% per quarter

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 3 months, HQL stock has moved up by 7.7%

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, HQL has outperformed top 5 stocks with highest market-cap in its industry

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Brookfield Corp has given 110.4% return, outperforming this stock by 84.1%

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 2 quarters, 18.19M → 11.63M (in $), with an average decrease of 36.1% per quarter

About Tekla Life Sciences Investors

Abrdn Life Sciences Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical equipment, hospitals, healthcare information technology and services, devices and supplies industries, and in agriculture and environmental management industries. The fund primarily invests in growth stocks of small cap companies. It employs fundamental analysis with a focus on factors such as market position for services or products, experience of business management, technological expertise, and the ability either to generate funds internally to finance growth or to secure outside sources of capital to create its portfolio. The fund benchmarks the performance of its portfolio against the NASDAQ Biotech Index and the S&P 500 Index. Abrdn Life Sciences Investors was formed on February 20, 1992 and is domiciled in the United States.
OrganisationTekla Life Sciences Investors
Headquarters1900 Market Street, Philadelphia, PA, United States, 19103
IndustryAsset Management
CEODr. Daniel R. Omstead M.S, Ph.D.
E-voting on sharesClick here to vote

Key Management of Tekla Life Sciences Investors

Name

Title

Dr. Daniel R. Omstead M.S, Ph.D.

Principal Executive Officer, President and Trustee

Mr. Peter Branner

Chief Investment Officer

FAQs

What is Tekla Life Sciences Investors share price today?

Tekla Life Sciences Investors share price today is $18.09 as on at the close of the market. Tekla Life Sciences Investors share today touched a day high of $18.1 and a low of $17.87.

What is the 52 week high and 52 week low for Tekla Life Sciences Investors share?

Tekla Life Sciences Investors share touched a 52 week high of $17.96 on and a 52 week low of $11.72 on . Tekla Life Sciences Investors stock price today i.e. is closed at $18.09,which is -0.72% down from its 52 week high and 54.35% up from its 52 week low.

What is Tekla Life Sciences Investors's market capitalisation today?

Tekla Life Sciences Investors market capitalisation is $0.00T as on .

How to invest in Tekla Life Sciences Investors Stock (HQL) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Tekla Life Sciences Investors on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Tekla Life Sciences Investors Shares that will get you 0.0829 shares as per Tekla Life Sciences Investors share price of $18.09 per share as on April 18, 2026 at 1:29 am IST.

What is the minimum amount required to buy Tekla Life Sciences Investors Stock (HQL) from India?

Indian investors can start investing in Tekla Life Sciences Investors (HQL) shares with as little as ₹92.768 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹927.68 in Tekla Life Sciences Investors stock (as per the Rupee-Dollar exchange rate as on ). Based on Tekla Life Sciences Investors share’s latest price of $18.09 as on April 18, 2026 at 1:29 am IST, you will get 0.5528 shares of Tekla Life Sciences Investors. Learn more about fractional shares .

What are the returns that Tekla Life Sciences Investors has given to Indian investors in the last 5 years?

Tekla Life Sciences Investors stock has given -10.82% share price returns and 25.08% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?